15 unchanged sentences
Other Information
+Added: Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Certain information required by Part III is omitted from this report because we intend to file a definitive Proxy Statement pursuant to Regulation 14A (the “Proxy Statement”) no later than 120 days after the end of the fiscal year covered by this report, and certain information to be included therein is incorporated herein by reference.
14 unchanged sentences
Financial Statements
−Removed: Report of independent registered public accounting firm
+Added: Report of independent registered public accounting firm (PCAOB ID:
Report of independent registered public accounting firm
−Removed: Consolidated Balance Sheets at January 2, 2021 and December 28, 2019
−Removed: Consolidated Statements of Income for the fiscal years ended January 2, 2021, December 28, 2019 and December 29, 2018
−Removed: Consolidated Statements of Comprehensive Income for the fiscal years ended January 2, 2021, December 28, 2019 and December 29, 2018
−Removed: Consolidated Statements of Changes in Stockholders' Equity for the fiscal years ended January 2, 2021, December 28, 2019 and December 29, 2018
−Removed: Consolidated Statements of Cash Flows for the fiscal years ended January 2, 2021, December 28, 2019 and December 29, 2018
+Added: Consolidated Balance Sheets at January 1, 2022 and January 2, 2021
+Added: Consolidated Statements of Income for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019
+Added: Consolidated Statements of Comprehensive Income for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019
+Added: Consolidated Statements of Changes in Stockholders’ Equity for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019
+Added: Consolidated Statements of Cash Flows for the fiscal years ended January 1, 2022, January 2, 2021 and December 28, 2019
Notes to Consolidated Financial Statements
1 unchanged sentence
The exhibits listed on the accompanying index to exhibits immediately following the Consolidated Financial Statements are filed as part of, or hereby incorporated by reference into, this Form 10-K.
−Removed: Asset Purchase Agreement, dated March 11, 2020, by and among Silicon Laboratories Inc., Silicon Laboratories International Pte.
−Removed: and Redpine Signals, Inc.
−Removed: (filed as Exhibit 2.1 to the Form 8-K filed on March 12, 2020).
+Added: The following exhibits are filed as part of this report:
+Added: Asset Purchase Agreement dated April 22, 2021 between Silicon Laboratories Inc.
+Added: and Skyworks Solutions, Inc.
+Added: (filed as Exhibit 2.1 to the Form 8-K filed on April 22, 2021).
Form of Fourth Amended and Restated Certificate of Incorporation of Silicon Laboratories Inc.
1 unchanged sentence
333-94853) (the “IPO Registration Statement”)).
−Removed: Fourth Amended and Restated Bylaws of Silicon Laboratories Inc.
−Removed: (filed as Exhibit 3.2 to the Form 8-K filed on January 27, 2017).
+Added: Fifth Amended and Restated Bylaws of Silicon Laboratories Inc.
+Added: (filed as Exhibit 3.1 to the Form 8-K filed on February 3, 2021).
Specimen certificate for shares of common stock (filed as Exhibit 4.1 to the IPO Registration Statement).
14 unchanged sentences
Security and Pledge Agreement, dated July 31, 2012, by and among Silicon Laboratories Inc., with the other parties identified as “Obligors” (as defined therein) and such other parties that may become Obligors thereunder after the date thereof, and Bank of America, N.A (filed as Exhibit 10.2 to the Form 8-K filed August 1, 2012).
−Removed: Silicon Laboratories Inc.
−Removed: 2009 Stock Incentive Plan, as amended and restated on April 20, 2017 (filed as Exhibit 10.1 to the Form 10-Q filed on July 26, 2017).
−Removed: Silicon Laboratories Inc.
−Removed: 2009 Employee Stock Purchase Plan, as amended and restated on April 20, 2017 (filed as Exhibit 10.2 to the Form 10-Q filed on July 26, 2017).
Form of Restricted Stock Units Grant Notice and Global Restricted Stock Units Award Agreement under Registrant’s 2009 Stock Incentive Plan, as amended and restated (filed as Exhibit 10.7 to the Form 10-K filed on February 1, 2017).
5 unchanged sentences
and Wells Fargo Securities, LLC, as representatives of the several initial purchasers named therein, dated February 28, 2017 (filed as Exhibit 10.1 to the Form 8-K filed on March 6, 2017).
−Removed: CEO Change in Control Agreement dated October 23, 2018 between Silicon Laboratories Inc.
−Removed: Tyson Tuttle (filed as Exhibit 10.1 to the Form 8-K filed on October 24, 2018).
Silicon Laboratories Inc.
−Removed: Form of Change in Control Agreement (filed as Exhibit 10.2 to the Form 8-K filed on October 24, 2018).
+Added: 2021 Bonus Plan (filed as Exhibit 10.1 to the Form 8-K filed on February 3, 3021).
Silicon Laboratories Inc.
−Removed: 2020 Bonus Plan (filed as Exhibit 10.1 to the Form 8-K filed on January 24, 2020).
+Added: Form of CEO Severance Agreement (filed as Exhibit 10.1 to the Form 8-K filed on May 17, 2021).
+Added: Silicon Laboratories Inc.
+Added: Form of Executive Severance Agreement (filed as Exhibit 10.2 to the Form 8-K filed on May 17, 2021).
+Added: Silicon Laboratories Inc.
+Added: Form of Performance Stock Units Grant Notice and Global PSU Award Agreement under Registrant’s 2009 Stock Incentive Plan, as amended and restated (filed as Exhibit 10.3 to the Form 8-K filed on May 17, 2021).
+Added: Silicon Laboratories Inc.
+Added: 2009 Stock Incentive Plan (As Amended and Restated on April 22, 2021) (filed as Exhibit 4.3 to the Form S-8 filed on May 5, 2021).
+Added: Silicon Laboratories Inc.
+Added: 2009 Employee Stock Purchase Plan (As Amended and Restated on April 22, 2021) (filed as Exhibit 4.4 to the Form S-8 filed on May 5, 2021).
+Added: CEO Transition Agreement between G.
+Added: Tyson Tuttle and Silicon Laboratories Inc.
+Added: dated July 27, 2021 (filed as Exhibit 10.1 to the Form 8-K filed on July 28, 2021).
+Added: ASR Agreement dated October 27, 2021 between Silicon Laboratories Inc.
+Added: and Goldman Sachs & Co.
+Added: LLC (filed as Exhibit 10.1 to the Form 8-K filed on October 28, 2021).
+Added: Silicon Laboratories Inc.
+Added: Form of Performance Stock Units Grant Notice and Global PSU Award Agreement under Registrant’s 2009 Stock Incentive Plan, as amended and restated (filed as Exhibit 10.1 to the Form 8-K filed on December 23, 2021).
Subsidiaries of the Registrant.
16 unchanged sentences
SILICON LABORATORIES INC.
−Removed: President and Chief Executive Officer
+Added: Matthew Johnson
+Added: Matthew Johnson
+Added: President and
+Added: Chief Executive Officer
POWER OF ATTORNEY
−Removed: KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints G.
−Removed: Tyson Tuttle and John C.
+Added: KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints R.
+Added: Matthew Johnson and John C.
Hollister and each of them, acting individually, as his or her attorney-in-fact, each with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this annual report on Form 10-K and other documents in connection herewith and therewith, and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection herewith and therewith and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
3 unchanged sentences
February 2, 2022
+Added: Matthew Johnson
President, Chief Executive Officer and Director
−Removed: (Principal Executive Officer)
February 2, 2022
+Added: Matthew Johnson
+Added: (Principal Executive Officer)
Senior Vice President and Chief Financial Officer
−Removed: (Principal Financial Officer and Principal Accounting Officer)
February 2, 2022
+Added: (Principal Financial Officer)
+Added: Chief Accounting Officer
+Added: February 2, 2022
+Added: (Principal Accounting Officer)
/s/ William G.
3 unchanged sentences
February 2, 2022
+Added: /s/ Sherri Luther
+Added: February 2, 2022
+Added: Sherri Luther
/s/ Nina Richardson
10 unchanged sentences
The Board of Directors and Stockholders of Silicon Laboratories Inc.
−Removed: Opinion on Internal Control Over Financial Reporting
−Removed: We have audited Silicon Laboratories Inc.’s internal control over financial reporting as of January 2, 2021, based on criteria established in Internal Control— Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria).
−Removed: In our opinion, Silicon Laboratories Inc.
−Removed: (the Company) maintained, in all material respects, effective internal control over financial reporting as of January 2, 2021, based on the COSO criteria.
−Removed: We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of Silicon Laboratories Inc.
−Removed: as of January 2, 2021 and December 28, 2019, the related consolidated statements of income, comprehensive income, changes in stockholders’ equity and cash flows for each of the three years in the period ended January 2, 2021, and the related notes and our report dated February 3, 2021 expressed an unqualified opinion thereon.
−Removed: Basis for Opinion
−Removed: The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting.
−Removed: Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.
−Removed: We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S.
−Removed: federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
−Removed: We conducted our audit in accordance with the standards of the PCAOB.
−Removed: Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
−Removed: Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances.
−Removed: We believe that our audit provides a reasonable basis for our opinion.
−Removed: Definition and Limitations of Internal Control Over Financial Reporting
−Removed: A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
−Removed: A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;
−Removed: (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company;
−Removed: and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
−Removed: Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
−Removed: Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
−Removed: /s/ Ernst & Young LLP
−Removed: Austin, Texas
−Removed: February 3, 2021
−Removed: Report of Independent Registered Public Accounting Firm
−Removed: The Board of Directors and Stockholders of Silicon Laboratories Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Silicon Laboratories Inc.
−Removed: (the Company) as of January 2, 2021 and December 28, 2019, the related consolidated statements of income, comprehensive income, changes in stockholders' equity and cash flows for each of the three years in the period ended January 2, 2021, and the related notes (collectively referred to as the “consolidated financial statements”).
−Removed: In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at January 2, 2021 and December 28, 2019, and the results of its operations and its cash flows for each of the three years in the period ended January 2, 2021, in conformity with U.S.
+Added: (the Company) as of January 1, 2022 and January 2, 2021, the related consolidated statements of income, comprehensive income, changes in stockholders’ equity and cash flows for each of the three years in the period ended January 1, 2022, and the related notes (collectively referred to as the “consolidated financial statements”).
+Added: In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at January 1, 2022 and January 2, 2021, and the results of its operations and its cash flows for each of the three years in the period ended January 1, 2022, in conformity with U.S.
generally accepted accounting principles.
27 unchanged sentences
For example, we tested controls over management’s review of the variable consideration methodology, the significant assumptions and the historical data utilized in the estimate for assumed product returns and expected price concessions.
−Removed: To test the variable consideration recognized as revenue and the revenue returns liability, we performed audit procedures that included, among others, an evaluation of the Company’s methodology and significant assumptions, and tested the completeness and accuracy of the historical data utilized in the estimate.
−Removed: In our assessment of the methodology, we considered changes in the business, changes to specific distributor contracts and evaluated significant assumptions used by comparison to current trends and recent transactions.
+Added: To test the variable consideration recognized as revenue and the revenue returns liability, we performed audit procedures that included, among others, an evaluation of the Company’s methodology and significant assumptions and estimates, and tested the completeness and accuracy of the historical data utilized in the estimates.
+Added: In our assessment of the methodology, we considered changes in the business, changes to specific distributor contracts, and evaluated significant assumptions used by management by comparison to current trends and recent transactions.
We also evaluated the accuracy of management’s assumed product returns and expected price concessions from prior periods by comparing to subsequent actual activity.
−Removed: Accounting for Acquisition
+Added: Accounting for Discontinued Operations
Description of the Matter
−Removed: As discussed in Note 8 of the financial statements, on April 28, 2020, the Company acquired the Wi-Fi and Bluetooth business of Redpine Signals, Inc.
−Removed: for total acquisition consideration of $317 million.
−Removed: The transaction was accounted for as a business combination in accordance with Accounting Standards Codification (ASC) 805.
−Removed: Auditing the Company’s accounting for the Redpine Signals acquisition was complex and judgmental due to the significant estimation required by management to determine the fair value of the acquired intangible assets, including developed technology and in-process research and development assets of $62 million and $12 million, respectively.
−Removed: The Company used variations of the income valuation approach, including the discounted expected future cash flow method, to measure the fair value of these intangible assets.
−Removed: Significant assumptions used to estimate the fair value of these intangible assets included revenue growth rates, technology migration curves and discount rates.
−Removed: These assumptions are forward-looking and could be affected by future economic and market conditions.
+Added: As discussed in Note 3 of the consolidated financial statements, on July 26, 2021, the Company completed the sale of its Infrastructure and Automotive (“I&A”) business to Skyworks Solutions, Inc.
+Added: for $2.75 billion in cash.
+Added: In connection with the sale, the Company recognized a pre-tax gain of $2.4 billion in discontinued operations.
+Added: As a result of the discontinued operations classification, the comparative period consolidated financial statements for fiscal years 2020 and 2019 have been recast to reclassify balance sheet, income statement and cash flow amounts related to the infrastructure and automotive business as discontinued operations.
+Added: Auditing the Company’s discontinued operations was complex due to judgments made by management to calculate the gain on sale, including allocating goodwill between the I&A and Internet of Things (IoT) business lines as well as the non-routine process used by management to compile historical financial data for the I&A business, which involved certain judgments in allocating expenses to the discontinued operations.
How We Addressed the Matter in Our Audit
−Removed: We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s accounting for acquisitions.
−Removed: For example, we tested controls over management’s review of the valuation of acquired intangible assets, including the review of the valuation models and significant assumptions used in the valuation models.
−Removed: To test the estimated fair value of these intangible assets, our audit procedures included, among others, evaluating the Company’s valuation methodology, evaluating the significant assumptions used by the Company and evaluating the completeness and accuracy of the underlying data supporting the significant assumptions and estimates.
−Removed: For example, we compared the significant assumptions used to current industry, market and economic trends, to the assumptions used to value similar assets in other acquisitions, and to the historical results of both the Company and the acquiree.
−Removed: We also involved our valuation specialists to assist with our evaluation of the methodology used by the Company and significant assumptions included in the fair value estimates.
+Added: We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s accounting for the discontinued operations.
+Added: For example, we tested controls over management’s treatment of the sale and calculation of the gain on sale, which included management’s review of the methodologies and assumptions used in the gain on sale calculation as well as controls over the disclosure of discontinued operations, including recasting prior period comparative financial statements.
+Added: Our audit procedures included, among others, testing the accuracy of the gain on sale calculation and evaluating the adequacy of the company’s disclosures related to discontinued operations.
+Added: For example, we evaluated the appropriateness of the company’s application of the criteria for reporting of discontinued operations by inspecting management’s supporting documentation, reading of board of director meeting minutes and other entity information, and evaluating for contrary evidence based on our understanding of the business.
+Added: To test the gain recognized in discontinued operations, we performed audit procedures that included testing the existence and valuation of cash proceeds;
+Added: inspecting the related sale agreement to obtain an understanding of the assets and liabilities included in the scope of the sales transaction and testing the completeness and accuracy of the assets and liabilities included in the gain calculation on a sample basis by comparing amounts to the Company’s accounting records and testing the tax effects of the sale.
+Added: To test the allocation of goodwill between the I&A and IoT business lines, we involved our valuation specialists to evaluate the reasonableness of the Company’s valuation methodology and significant assumptions used to allocate goodwill.
+Added: For example, we compared the significant assumptions used by the Company to current market and economic trends, to the assumptions used to value similar assets in other relevant divestitures, and to the historical results of the Company.
+Added: We performed procedures to audit the presentation of discontinued operations in the financial statements, including testing the recast prior period financial statements and assessing the reasonableness of key judgments applied by management in allocating expenses to the discontinued operations.
/s/ Ernst & Young LLP
2 unchanged sentences
February 2, 2022
+Added: Report of Independent Registered Public Accounting Firm
+Added: The Board of Directors and Stockholders of Silicon Laboratories Inc.
+Added: Opinion on Internal Control Over Financial Reporting
+Added: We have audited Silicon Laboratories Inc.’s internal control over financial reporting as of January 1, 2022, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria).
+Added: In our opinion, Silicon Laboratories Inc.
+Added: (the Company) maintained, in all material respects, effective internal control over financial reporting as of January 1, 2022, based on the COSO criteria.
+Added: We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of Silicon Laboratories Inc.
+Added: as of January 1, 2022 and January 2, 2021, the related consolidated statements of income, comprehensive income, changes in stockholders’ equity and cash flows for each of the three years in the period ended January 1, 2022, and the related notes and our report dated February 2, 2022 expressed an unqualified opinion thereon.
+Added: Basis for Opinion
+Added: The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting.
+Added: Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.
+Added: We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S.
+Added: federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
+Added: We conducted our audit in accordance with the standards of the PCAOB.
+Added: Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
+Added: Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances.
+Added: We believe that our audit provides a reasonable basis for our opinion.
+Added: Definition and Limitations of Internal Control Over Financial Reporting
+Added: A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
+Added: A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;
+Added: (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company;
+Added: and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
+Added: Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
+Added: Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
+Added: /s/ Ernst & Young LLP
+Added: Austin, Texas
+Added: February 2, 2022
Silicon Laboratories Inc.
6 unchanged sentences
Prepaid expenses and other current assets
+Added: Current assets of discontinued operations
Total current assets
2 unchanged sentences
Other assets, net
+Added: Non-current assets of discontinued operations
Liabilities and Stockholders’ Equity
4 unchanged sentences
Other current liabilities
+Added: Current liabilities of discontinued operations
Total current liabilities
1 unchanged sentence
Other non-current liabilities
+Added: Non-current liabilities of discontinued operations
Total liabilities
6 unchanged sentences
250,000 shares authorized;
−Removed: 43,925 and 43,496 shares issued and outstanding at January 2, 2021 and December 28, 2019, respectively
+Added: 38,481 and 43,925 shares issued and outstanding at January 1, 2022 and January 2, 2021, respectively
Additional paid-in capital
Retained earnings
−Removed: Accumulated other comprehensive income
+Added: Accumulated other comprehensive income (loss)
Total stockholders’ equity
9 unchanged sentences
Operating expenses
−Removed: Operating income
+Added: Operating loss
Other income (expense):
1 unchanged sentence
Interest expense
−Removed: Income before income taxes
+Added: Loss from continuing operations before income taxes
Provision (benefit) for income taxes
−Removed: Earnings per share:
+Added: Equity-method earnings
+Added: Loss from continuing operations
+Added: Income from discontinued operations, net of income taxes
+Added: Basic earnings (loss) per share:
+Added: Continuing operations
+Added: Diluted earnings (loss) per share:
+Added: Continuing operations
Weighted-average common shares outstanding:
5 unchanged sentences
Net changes to available-for-sale securities:
−Removed: Unrealized gains arising during the period
−Removed: Reclassification for (gains) losses included in net income
+Added: Unrealized gains (losses) arising during the period
+Added: Reclassification for gains included in net income
Net changes to cash flow hedges:
Unrealized gains (losses) arising during the period
−Removed: Reclassification for losses included in net income
+Added: Reclassification for (gains) losses included in net income
Other comprehensive income (loss), before tax
6 unchanged sentences
(In thousands)
−Removed: Accumulated Other
Comprehensive
2 unchanged sentences
Balance as of December 29, 2018
−Removed: Cumulative effect of adoption of accounting standard
−Removed: Other comprehensive loss
+Added: Other comprehensive income
Stock issuances, net of shares withheld for taxes
2 unchanged sentences
Balance as of December 28, 2019
+Added: Cumulative effect of adoption of accounting standard
Other comprehensive income
2 unchanged sentences
Stock-based compensation
−Removed: Balance as of December 28, 2019
−Removed: Cumulative effect of adoption of accounting standard
−Removed: Other comprehensive income
+Added: Convertible debt activity
+Added: Balance as of January 2, 2021
+Added: Other comprehensive loss
Stock issuances, net of shares withheld for taxes
Repurchases of common stock
+Added: ( 1,150,044 )
Stock-based compensation
6 unchanged sentences
Operating Activities
−Removed: Adjustments to reconcile net income to cash provided by operating activities:
+Added: Adjustments to reconcile net income to cash provided by (used in) operating activities of continuing operations:
+Added: Income from discontinued operations, net of income taxes
+Added: ( 2,175,273 )
Depreciation of property and equipment
−Removed: Amortization of other intangible assets and other assets
+Added: Amortization of other intangible assets
Amortization of debt discount and debt issuance costs
1 unchanged sentence
Stock-based compensation expense
+Added: Equity-method earnings
Deferred income taxes
6 unchanged sentences
Other non-current liabilities
−Removed: Net cash provided by operating activities
+Added: Net cash provided by (used in) operating activities of continuing operations
Investing Activities
−Removed: Purchases of available-for-sale investments
−Removed: Sales and maturities of available-for-sale investments
+Added: Purchases of marketable securities
+Added: ( 1,541,971 )
+Added: Sales and maturities of marketable securities
Purchases of property and equipment
1 unchanged sentence
Acquisitions of businesses, net of cash acquired
−Removed: Net cash used in investing activities
+Added: Net cash used in investing activities of continuing operations
Financing Activities
2 unchanged sentences
Repurchases of common stock
+Added: ( 1,150,044 )
Payment of taxes withheld for vested stock awards
Proceeds from the issuance of common stock
−Removed: Payment of acquisition-related contingent consideration
−Removed: Net cash provided by (used in) financing activities
+Added: Net cash provided by (used in) financing activities of continuing operations
+Added: ( 1,298,672 )
+Added: Discontinued Operations
+Added: Operating activities
+Added: Investing activities
+Added: Net cash provided by discontinued operations
Increase (decrease) in cash and cash equivalents
10 unchanged sentences
Silicon Laboratories Inc.
−Removed: (the “Company”), a Delaware corporation, is a leading provider of silicon, software and solutions for a smarter, more connected world.
−Removed: Our award-winning technologies are shaping the future of the Internet of Things (IoT), internet infrastructure, industrial automation, consumer and automotive markets.
−Removed: Within the semiconductor industry, the Company is known as a "fabless"
−Removed: company meaning that the integrated circuits (ICs) incorporated in its products are manufactured by third-party foundry semiconductor companies.
+Added: (the “Company”), a Delaware corporation, is a leader in secure, intelligent wireless technology for a more connected world.
+Added: Our integrated hardware and software platform, intuitive development tools, industry leading ecosystem and robust support enable customers in building advanced industrial, commercial, home and life applications.
+Added: The Company provides analog-intensive, mixed-signal solutions for use in a variety of electronic products in a broad range of applications for the Internet of Things (IoT) including connected home and security, industrial automation and control, smart metering, smart lighting, commercial building automation, consumer electronics, asset tracking and medical instrumentation.
+Added: Within the semiconductor industry, the Company is known as a “fabless” company meaning that the integrated circuits (ICs) incorporated in its products are manufactured by third-party foundry semiconductor companies.
+Added: On April 22, 2021, the Company entered into an Asset Purchase Agreement pursuant to which Skyworks Solutions, Inc.
+Added: agreed to acquire certain assets, rights, and properties, and assume certain liabilities, comprising the Company’s infrastructure and automotive business for $ 2.75 billion in cash.
+Added: The transaction closed on July 26, 2021.
+Added: The financial results of the infrastructure and automotive business have been presented as discontinued operations in the Consolidated Financial Statements because the sale represented a strategic shift for the Company.
+Added: Prior period financial statements have been reclassified to reflect these changes for all periods presented.
+Added: See Note 3, Discontinued Operations , for additional information.
+Added: Unless indicated otherwise, the information in the Notes to the Consolidated Financial Statements relates to the Company’s continuing operations and does not include the results of discontinued operations.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
Significant Accounting Policies
1 unchanged sentence
The Company prepares financial statements on a 52 - or 53 -week fiscal year that ends on the Saturday closest to December 31.
−Removed: Fiscal 2020 had 53 weeks with the extra week occurring in the first quarter of the year and ended on January 2, 2021.
−Removed: Fiscal 2019 and 2018 had 52 weeks and ended on December 28, 2019 and December 29, 2018, respectively.
+Added: Fiscal 2021 had 52 weeks.
+Added: Fiscal 2020 had 53 weeks with the extra week occurring in the first quarter of the year.
+Added: Fiscal 2019 had 52 weeks.
+Added: Fiscal 2021, 2020 and 2019 ended on January 1, 2022, January 2, 2021 and December 28, 2019, respectively.
The accompanying Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries.
6 unchanged sentences
Use of Estimates
−Removed: The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.
+Added: The preparation of financial statements in conformity with U.S.
+Added: generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.
Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation and income taxes.
Actual results could differ from those estimates, and such differences could be material to the financial statements.
−Removed: Adoption of New Financial Instruments Accounting Standard
−Removed: The Company adopted Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) No.
−Removed: 2016-13, Financial Instruments—Credit Losses (Topic 326):
−Removed: Measurement of Credit Losses on Financial Instruments , on December 29, 2019, the first day of its fiscal year ended January 2, 2021.
−Removed: The adoption did not have a material impact on its financial statements.
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Significant Accounting Policies (Continued)
Fair Value of Financial Instruments
2 unchanged sentences
Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.
−Removed: Level 2 - Inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
+Added: Level 2 - Inputs other than Level 1 that are directly or indirectly observable, such as quoted prices for similar assets or liabilities and quoted prices in less active markets.
Level 3 - Inputs are unobservable for the asset or liability and are developed based on the best information available in the circumstances, which might include the Company’s own data.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Significant Accounting Policies (Continued)
Cash and Cash Equivalents
12 unchanged sentences
Equity investments in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.
−Removed: The Company’s proportionate share of income or loss is recorded in interest income and other, net in the Consolidated Statement of Income.
−Removed: All other non-marketable equity investments are recorded at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.
−Removed: The Company periodically reviews its equity investments for declines in fair value based on the specific identification method and writes down investments to their fair values when it determines that a decline has occurred.
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Significant Accounting Policies (Continued)
+Added: The Company’s proportionate share of income or loss is recorded in equity-method earning in the Consolidated Statements of Income.
+Added: The Company has elected to use the measurement alternative under ASU 2019-04 to value non-marketable equity investments that do not have readily determinable fair values.
+Added: Under the alternative, these non-marketable equity investments are recorded at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes of the same or similar securities in observable transactions.
+Added: The Company periodically reviews its equity investments for declines in fair value based on the specific identification method and writes down investments to their estimated fair values when it determines that a decline has occurred.
Derivative Financial Instruments
−Removed: The Company uses derivative financial instruments to manage certain exposures to the variability of foreign currency exchange rates and interest rates.
+Added: The Company uses derivative financial instruments to manage certain exposures to the variability of foreign currency exchange rates.
The Company’s objective is to offset increases and decreases in expenses resulting from these exposures with gains and losses on the derivative contracts, thereby reducing volatility of earnings.
2 unchanged sentences
Cash flows from derivatives are classified according to the nature of the cash receipt or payment in the Consolidated Statement of Cash Flows.
−Removed: Cash flow hedges used by the Company include foreign currency forward contracts and interest rate swap agreements.
−Removed: Foreign currency forward contracts are used to reduce the earnings impact that exchange rate fluctuations have on operating expenses denominated in currencies other than the U.S.
−Removed: Interest rate swap agreements are used to manage exposure to interest rate risks.
The Company also uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-U.S.
1 unchanged sentence
The Company does not apply hedge accounting to these foreign currency forward contracts.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Significant Accounting Policies (Continued)
Inventories are stated at the lower of cost, determined using the first-in, first-out method, or net realizable value.
16 unchanged sentences
Fair values are determined primarily using the income approach, in which the Company projects future expected cash flows and applies an appropriate discount rate.
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Significant Accounting Policies (Continued)
Long-lived assets “held and used” by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable.
5 unchanged sentences
If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized equal to that excess amount.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Significant Accounting Policies (Continued)
At the commencement date of a lease, the Company recognizes a liability to make lease payments and an asset representing the right to use the underlying asset during the lease term.
8 unchanged sentences
Revenue Recognition
−Removed: Revenue is recognized when control of the promised goods or services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.
+Added: Revenue is recognized when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.
Substantially all of the Company’s contracts with customers contain a single performance obligation, the sale of mixed-signal integrated circuit (IC) products.
12 unchanged sentences
Payments are typically due within 30 days of invoicing and do not include a significant financing component.
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Significant Accounting Policies (Continued)
Shipping and Handling
7 unchanged sentences
Assets purchased to support the Company’s ongoing research and development activities are capitalized when related to products which have achieved technological feasibility or have an alternative future use, and are amortized over their estimated useful lives.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Significant Accounting Policies (Continued)
Advertising costs are expensed as incurred.
1 unchanged sentence
The Company accounts for income taxes using the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax laws and related rates that will be in effect when the differences are expected to reverse.
−Removed: These differences result in deferred tax assets and liabilities, which are included in the Company’s Consolidated Balance Sheet.
+Added: These differences result in deferred tax assets and liabilities, which are included in the Company’s Consolidated Balance Sheets.
The Company then assesses the likelihood that the deferred tax assets will be realized.
3 unchanged sentences
Recent Accounting Pronouncements
−Removed: In August 2020, the FASB issued ASU No.
+Added: In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No.
2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40) .
2 unchanged sentences
Such convertible instruments will be accounted for as a single liability measured at amortized cost, as long as no other features require bifurcation and recognition as derivatives.
−Removed: This ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, using one of two retrospective transition methods.
−Removed: Early adoption is permitted for fiscal periods beginning after December 15, 2020.
−Removed: The Company expects the primary impacts of this new standard will be to potentially increase the carrying value of its convertible debt and reduce its reported interest expense.
+Added: This ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years.
+Added: The Company will elect the modified retrospective transition method to account for the impact of the adoption with a cumulative-effect adjustment to the opening balance of retained earnings at the date of adoption.
+Added: The Company expects the primary impacts of this new standard will be to increase the carrying value of its convertible debt by approximately $ 78.5 million, with an offsetting reduction in stockholders’ equity, and reduce its reported interest expense.
In addition, should the Company be required to use the if-converted method for calculating diluted earnings per share, the number of shares used in such calculation could potentially increase.
−Removed: The Company will continue to evaluate the effect that the adoption of this ASU will have on its financial statements.
+Added: On January 2, 2022, the Company irrevocably elected cash settlement for the principal amount of its convertible senior notes.
+Added: The Company intends to settle any excess value in shares in the event of a conversion.
Silicon Laboratories Inc.
1 unchanged sentence
January 1, 2022
+Added: Discontinued Operations
+Added: On April 22, 2021, the Company entered into an Asset Purchase Agreement pursuant to which Skyworks Solutions, Inc.
+Added: agreed to acquire certain assets, rights, and properties, and assume certain liabilities, comprising the Company’s infrastructure and automotive business for $ 2.75 billion in cash.
+Added: The Company believes the sale accelerates its IoT market leadership and growth, making it a pure-play leader of intelligent, wireless connectivity for the IoT.
+Added: The transaction closed on July 26, 2021.
+Added: The financial results of the infrastructure and automotive business, which are readily distinguishable from other components of the Company, have been presented as discontinued operations in the Consolidated Financial Statements because the sale represented a strategic shift for the Company.
+Added: The following table presents the financial results of the infrastructure and automotive business (the “discontinued operations”) in the Company’s Consolidated Statements of Income (In thousands, except per share data):
+Added: Costs of revenues
+Added: Operating expenses
+Added: Operating income from discontinued operations
+Added: Gain on sale of discontinued operations
+Added: Income from discontinued operations before income taxes
+Added: Provision for income taxes
+Added: Income from discontinued operations
+Added: Income from discontinued operations per share:
+Added: The following table summarizes the assets and liabilities of the discontinued operations (in thousands):
+Added: Prepaid expenses and other current assets
+Added: Other current liabilities
+Added: Other non-current liabilities
+Added: Total liabilities
+Added: Continuing Involvement
+Added: In connection with the closing of the sale, the Company entered into certain ancillary agreements with Skyworks, including a Transition Services Agreement ("TSA").
+Added: Through the TSA, the Company has subleased certain premises to Skyworks and will provide or provides various temporary support services for three to eighteen months , depending on the service provided.
+Added: Although the services provided under the TSA will generate continuing cash flows between the Company and Skyworks for the duration of the TSA, the amounts are not expected to be material to the ongoing operations of either entity.
+Added: In addition, the Company has no contractual ability through the TSA or any other agreement to significantly influence the operating or financial policies of Skyworks.
+Added: The TSA fees were approximately $ 4.2 million for fiscal 2021.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):
−Removed: Shares used in computing basic earnings per share
+Added: Loss from continuing operations
+Added: Shares used in computing basic loss per share
Effect of dilutive securities:
Stock-based awards and convertible debt
−Removed: Shares used in computing diluted earnings per share
−Removed: Earnings per share:
+Added: Shares used in computing diluted loss per share
+Added: Loss per share:
+Added: Diluted shares for fiscal 2021, 2020 and 2019 excluded 1.5 million, 0.6 million and 0.9 million shares, respectively, due to the Company’s loss from continuing operations for the periods.
The Company intends to settle the principal amount of its convertible senior notes in cash and any excess value in shares in the event of a conversion.
−Removed: Accordingly, shares issuable upon conversion of the principal amount have been excluded from the calculation of diluted earnings per share.
+Added: Accordingly, shares issuable upon conversion of the principal amount using the treasury stock method have been excluded from the calculation of diluted earnings per share.
If the market value of the notes under certain prescribed conditions exceeds the conversion amount, the excess is included in the denominator for the computation of diluted earnings per share using the treasury stock method.
−Removed: For fiscal 2020, 2019 and 2018, approximately 0.2 million shares, 0.4 million shares and 0.1 million shares, respectively, were included in the denominator for the calculation of diluted earnings per share.
+Added: For fiscal 2021, 2020 and 2019 approximately 1.0 million shares, 0.2 million shares and 0.4 million shares, respectively, were included in the denominator for the calculation of diluted earnings per share from net income.
See Note 11, Debt , to the Consolidated Financial Statements for additional information.
22 unchanged sentences
Auction rate securities
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Fair Value of Financial Instruments (Continued)
Fair Value Measurements
−Removed: at December 28, 2019 Using
+Added: at January 2, 2021 Using
Quoted Prices in
5 unchanged sentences
Corporate debt securities
+Added: Government debt securities
Total cash equivalents
5 unchanged sentences
Auction rate securities
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Fair Value of Financial Instruments (Continued)
Valuation methodology
1 unchanged sentence
quoted market prices for similar instruments in active markets;
+Added: quoted prices in less active markets;
or pricing models, such as a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data.
2 unchanged sentences
The Company’s derivative instruments are valued using discounted cash flow models.
−Removed: The assumptions used in preparing the valuation models include quoted interest swap rates, foreign exchange rates, forward and spot prices for currencies, and market observable data of similar instruments.
−Removed: Available-for-sale investments
−Removed: The Company's investments are reported at fair value, with unrealized gains and losses, net of tax, recorded as a component of accumulated other comprehensive income in the Consolidated Balance Sheet.
+Added: The assumptions used in preparing the valuation models include foreign exchange rates, forward and spot prices for currencies and market observable data of similar instruments.
+Added: Contractual maturities of investments
+Added: The Company’s investments are reported at fair value, with unrealized gains and losses, net of tax, recorded as a component of accumulated other comprehensive income (loss) in the Consolidated Balance Sheet.
The following summarizes the contractual underlying maturities of the Company’s available-for-sale investments at January 1, 2022 (in thousands):
2 unchanged sentences
Due after ten years
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Fair Value of Financial Instruments (Continued)
+Added: Available-for-sale investments
The available-for-sale investments that were in a continuous unrealized loss position, aggregated by length of time that individual securities have been in a continuous loss position, were as follows (in thousands):
7 unchanged sentences
12 Months or Greater
−Removed: As of December 28, 2019
+Added: As of January 2, 2021
Government debt securities
1 unchanged sentence
Auction rate securities
−Removed: The gross unrealized losses as of January 2, 2021 and December 28, 2019 were due primarily to changes in market interest rates and the illiquidity of the Company’s auction-rate securities.
+Added: The gross unrealized losses as of January 1, 2022 and January 2, 2021 were due primarily to changes in market interest rates and the illiquidity of the Company’s auction-rate securities.
The Company’s auction-rate securities have been illiquid since 2008 when auctions for the securities failed because sell orders exceeded buy orders.
1 unchanged sentence
The Company is unable to predict if these funds will become available before their maturity date.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Fair Value of Financial Instruments (Continued)
The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors.
1 unchanged sentence
As of January 1, 2022, there were no material declines in the market value of available-for-sale investments due to credit-related factors.
−Removed: At January 2, 2021 and December 28, 2019, there were no material unrealized gains associated with the Company's available-for-sale investments.
+Added: At January 1, 2022 and January 2, 2021, there were no material unrealized gains associated with the Company’s available-for-sale investments.
Level 3 fair value measurements
5 unchanged sentences
Unobservable Input
+Added: Weighted Average
Discounted cash flow
2 unchanged sentences
Estimated discount rate
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Fair Value of Financial Instruments (Continued)
Significant changes in any of the unobservable inputs used in the fair value measurement of auction rate securities in isolation could result in a significantly lower or higher fair value measurement.
1 unchanged sentence
Generally, a change in the assumptions used for expected holding period is accompanied by a directionally similar change in the assumptions used for estimated yield and discount rate.
−Removed: The following summarizes the activity in Level 3 financial instruments for the years ended January 2, 2021 and December 28, 2019 (in thousands):
+Added: The following summarizes the activity in Level 3 financial instruments for the years ended January 1, 2022 and January 2, 2021 (in thousands):
Auction Rate Securities
5 unchanged sentences
The notes are traded in less active markets and are therefore classified as a Level 2 fair value measurement.
−Removed: As of January 2, 2021 and December 28, 2019, the fair value of the 1.375 % convertible senior notes was $ 194.8 million and $ 524.0 million, respectively.
−Removed: The fair value of the 0.625 % convertible senior notes as of January 2, 2021 was $ 671.4 million.
+Added: As of January 1, 2022 and January 2, 2021, the fair value of the 0.625 % convertible senior notes due in 2025 was $ 944.3 million and $ 671.4 million, respectively.
The Company’s other financial instruments, including cash, accounts receivable and accounts payable, are recorded at amounts that approximate their fair values due to their short maturities.
−Removed: Derivative Financial Instruments
−Removed: The Company uses derivative financial instruments to manage certain exposures to the variability of foreign currency exchange rates and interest rates.
−Removed: The Company’s objective is to offset increases and decreases in expenses resulting from these exposures with gains and losses on the derivative contracts, thereby reducing volatility of earnings.
−Removed: Cash Flow Hedges
−Removed: Foreign Currency Forward Contracts
−Removed: The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on operating expenses denominated in currencies other than the U.S.
−Removed: Changes in the fair value of the contracts are recorded in accumulated other comprehensive income (loss) in the Consolidated Balance Sheet and subsequently reclassified into earnings in the period during which the hedged transaction is recognized.
−Removed: The reclassified amount is reported in the same financial statement line item as the hedged item.
−Removed: If the foreign currency forward contracts are terminated or can no longer qualify as hedging instruments prior to maturity, the fair value of the contracts recorded in accumulated other comprehensive income (loss) may be recognized in the Consolidated Statement of Income based on an assessment of the contracts at the time of termination.
−Removed: The Company has entered into foreign currency forward contracts for a portion of its forecasted operating expenses denominated in the Euro, Norwegian Krone and Hungarian Forint.
−Removed: As of January 2, 2021, the contracts had maturities of one to twelve months and an aggregate notional value of $ 29.3 million.
−Removed: Gains expected to be reclassified into earnings in the next twelve months were not material.
−Removed: The fair value of the contracts, contract gains or losses recognized in other comprehensive income (loss) and amounts reclassified from accumulated other comprehensive income (loss) into earnings were not material for any of the periods presented.
Silicon Laboratories Inc.
1 unchanged sentence
January 1, 2022
−Removed: Derivative Financial Instruments (Continued)
−Removed: Interest Rate Swaps
−Removed: The Company entered into an interest rate swap agreement with an original notional value of $ 310 million in connection with borrowing from its credit facility on March 27, 2020.
−Removed: The Company terminated the swap agreement on June 1, 2020 in connection with the repayment in full of its credit facility.
−Removed: The termination of the swap agreement resulted in the reclassification of $ 0.4 million of unrealized losses that were previously recorded in accumulated other comprehensive income (loss) into earnings.
+Added: Derivative Financial Instruments
+Added: The Company uses derivative financial instruments to manage certain exposures to the variability of foreign currency exchange rates.
+Added: The Company’s objective is to offset increases and decreases in expenses resulting from these exposures with gains and losses on the derivative contracts, thereby reducing volatility of earnings.
Non-designated Hedges
4 unchanged sentences
The Company does not apply hedge accounting to these foreign currency forward contracts.
−Removed: As of January 2, 2021, the Company held two foreign currency forward contracts denominated in Singapore Dollars with a notional value of $ 11.9 million.
+Added: As of January 1, 2022, the Company held one foreign currency forward contract denominated in Singapore Dollars with a notional value of $ 3.7 million, and two foreign currency forward contracts denominated in Indian Rupees with an aggregate notional value of $ 7.4 million and one foreign currency forward contract denominated in the Hungarian Forint with a notional value of $ 2.1 million.
The fair value of foreign contracts and contract losses recognized in income were not material for any of the periods presented.
−Removed: Balance Sheet Details
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Supplemental Information
The following tables show the details of selected Consolidated Balance Sheet items (in thousands):
3 unchanged sentences
Distributor advances
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Balance Sheet Details (Continued)
Property and Equipment
5 unchanged sentences
Accumulated depreciation
+Added: Other Assets, net
+Added: Equity-method investment*
+Added: *The Company holds an 8 % equity interest in China Walden Venture Investments III, a limited partnership.
Other Current Liabilities
Accrued compensation and benefits
+Added: Income taxes payable
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
Risks and Uncertainties
1 unchanged sentence
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash equivalents, investments, accounts receivable, notes receivable and derivatives.
−Removed: The Company places its cash equivalents and investments primarily in municipal bonds, money market funds, corporate bonds, variable-rate demand notes, U.S.
+Added: The Company places its cash equivalents and investments primarily in municipal bonds, money market funds, corporate bonds, certificates of deposit, U.S.
Treasury bills, U.S.
4 unchanged sentences
Edom Technology
−Removed: * Less than 10% of accounts receivable
The Company performs periodic credit evaluations of its customers’ financial condition and generally requires no collateral from its customers.
1 unchanged sentence
Losses have not been significant for any of the periods presented.
−Removed: The Company holds three notes receivable from a privately held company.
−Removed: The total carrying value of the notes was $ 1.6 million as of January 2, 2021.
−Removed: The Company holds an equity investment in another privately held company.
−Removed: The investment is accounted for using the equity method and had a carrying value of $ 10.1 million as of January 2, 2021.
−Removed: The notes receivable and the investment were recorded in other assets, net in the Consolidated Balance Sheet.
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Risks and Uncertainties (Continued)
As a result of its use of derivative instruments, the Company is exposed to the risk that its counterparties will fail to meet their contractual obligations.
14 unchanged sentences
The inability of TSMC or SMIC to deliver wafers to the Company on a timely basis could impact the production of the Company’s products for a substantial period of time, which could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Risks and Uncertainties (Continued)
The Company sells directly to end customers, distributors and contract manufacturers.
4 unchanged sentences
Edom Technology
−Removed: Less than 10% of revenue
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
Redpine Signals
17 unchanged sentences
Total purchase price
−Removed: In-process research and development (IPR&D) represents Wi-Fi and Bluetooth technology that had not achieved technological feasibility as of the acquisition date.
−Removed: The fair value of IPR&D was determined using the income approach.
−Removed: The discount rate applied to the projected cash flows was 13.8 %, which reflects the risks related to the projects.
Pro forma information related to this acquisition has not been presented because it would not be materially different from amounts reported.
4 unchanged sentences
Goodwill and Other Intangible Assets
−Removed: The following summarizes the activity in goodwill for the years ended January 2, 2021 and December 28, 2019 (in thousands):
+Added: The following summarizes the activity in goodwill for the years ended January 1, 2022 and January 2, 2021 (in thousands):
Beginning balance
5 unchanged sentences
January 1, 2022
−Removed: December 28, 2019
+Added: January 2, 2021
Subject to amortization:
5 unchanged sentences
Total intangible assets
−Removed: Gross intangible assets increased $ 76.5 million in fiscal 2020 due to assets acquired from Redpine Signals.
−Removed: This increase was offset by $ 19.6 million for the removal of fully amortized assets.
−Removed: Amortization expense related to intangible assets for fiscal 2020, 2019 and 2018 was $ 44.7 million, $ 39.5 million and $ 38.0 million, respectively.
−Removed: Research and development expense included intangible asset amortization expense of $ 33.2 million, $ 29.5 million and $ 27.3 million in fiscal 2020, 2019 and 2018, respectively.
−Removed: Selling, general and administrative expense included intangible asset amortization expense of $ 11.5 million, $ 10.0 million and $ 10.7 million in fiscal 2020, 2019 and 2018, respectively.
−Removed: There was no intangible asset amortization expense recorded in cost of revenues in any of the periods presented.
+Added: Gross intangible assets decreased $ 32.5 million in fiscal 2021 due to the removal of fully amortized assets.
+Added: The following table presents details of intangible asset amortization expense recognized in the Consolidated Statements of Income (in thousands):
+Added: Research and development
+Added: Selling, general and administrative
The estimated aggregate amortization expense for intangible assets subject to amortization for each of the five succeeding fiscal years is as follows (in thousands):
5 unchanged sentences
The 2025 Notes bear interest semi-annually at a rate of 0.625 % per year and mature on June 15, 2025.
−Removed: The Company used $ 310.0 million of the proceeds to repay in full the outstanding balance under its credit facility and the remainder of the proceeds, along with cash on hand, to repurchase approximately $ 236.8 million aggregate principal amount of its outstanding 1.375 % convertible senior notes.
−Removed: The 2025 Notes are convertible at an initial conversion rate of 8.1498 shares of common stock per $1,000 principal amount of the 2025 Notes, or approximately 4.4 million shares of common stock, which is equivalent to a conversion price of approximately $ 122.70 per share.
−Removed: The conversion rate is subject to adjustment under certain circumstances.
+Added: The 2025 Notes are convertible at a conversion rate of 8.1980 shares of common stock per $1,000 principal amount of the 2025 Notes, or approximately 4.4 million shares of common stock, which is equivalent to a conversion price of approximately $ 121.98 per share.
+Added: The conversion rate is subject to adjustment under certain circumstances, such as the repurchases of common stock under a “modified Dutch Auction” tender offer completed during fiscal 2021.
Holders may convert the 2025 Notes under the following circumstances:
−Removed: during any calendar quarter after the calendar quarter ended on September 30, 2020 if the closing price of the Company’s common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to $ 159.51 per share, representing 130 % of the conversion price of the 2025 Notes;
+Added: during any calendar quarter after the calendar quarter ended on September 30, 2020 if the closing price of the Company’s common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to $ 159.51 per share, representing 130 % of the conversion price of the 2025 Notes (“the Sales Price Trigger”);
during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98 % of the product of the closing sale price of our common stock and the conversion rate on each such trading day;
4 unchanged sentences
Upon conversion, the 2025 Notes may be settled in cash, shares of the Company’s common stock or a combination of cash and shares, at the Company’s election.
+Added: The Sales Price Trigger condition was met on January 1, 2022, and as a result, holders may convert their 2025 Notes at any time during the quarter ending March 31, 2022.
+Added: Accordingly, the net carrying amount of the 2025 Notes was reclassified into current liabilities.
+Added: On January 2, 2022, the Company irrevocably elected cash settlement for the principal amount of the 2025 Notes.
+Added: The Company intends to settle any excess value in shares in the event of a conversion.
The Company incurred debt issuance costs of approximately $ 10.4 million, which was allocated to the liability and equity components in proportion to the allocation of the proceeds.
2 unchanged sentences
On March 6, 2017, the Company completed a private offering of $ 400 million principal amount convertible senior notes (the “2022 Notes”).
−Removed: The Notes bear interest semi-annually at a rate of 1.375 % per year and mature on March 1, 2022.
−Removed: The 2022 Notes are convertible at an initial conversion rate of 10.7744 shares of common stock per $1,000 principal amount of the 2022 Notes, or approximately 4.3 million shares of common stock, which is equivalent to a conversion price of approximately $ 92.81 per share.
−Removed: The conversion rate is subject to adjustment under certain circumstances.
−Removed: Holders may convert the 2022 Notes under the following circumstances:
−Removed: during any calendar quarter after the calendar quarter ended on June 30, 2017 if the closing price of the Company’s common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to $ 120.66 per share, representing 130 % of the conversion price of the 2022 Notes;
−Removed: during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98 % of the product of the closing sale price of our common stock and the conversion rate on each such trading day;
−Removed: if specified distributions or corporate events occur;
−Removed: if the 2022 Notes are called for redemption;
−Removed: or at any time after December 1, 2021.
−Removed: The Company may redeem all or any portion of the 2022 Notes, at its option, on or after March 6, 2020, if the last reported sale price of the Company’s common stock has been at least 130 % of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period.
−Removed: Upon conversion, the 2022 Notes may be settled in cash, shares of the Company’s common stock or a combination of cash and shares, at the Company’s election.
+Added: The Notes bore interest semi-annually at a rate of 1.375 % per year and were scheduled to mature on March 1, 2022.
+Added: On January 6, 2021, the Company issued a notice of redemption for the remaining $ 140.6 million principal amount of the 2022 Notes.
+Added: Prior to the redemption, the Company received conversion notices representing $ 130.4 million principal amount of the notes.
+Added: The Company paid $ 130.4 million in cash and issued 528,022 shares of common stock for the conversions.
+Added: Notes representing $ 10.2 million principal amount were redeemed at par, plus accrued interest.
+Added: All note conversions and redemptions were completed by March 22, 2021.
+Added: The Company recognized a loss on debt extinguishment of $ 3.4 million during fiscal 2021, which was recorded in interest expense in the Consolidated Statements of Income.
Silicon Laboratories Inc.
2 unchanged sentences
Debt (Continued)
−Removed: The Company incurred debt issuance costs of approximately $ 10.6 million, which was allocated to the liability and equity components in proportion to the allocation of the proceeds.
−Removed: The costs allocated to the liability component are being amortized as interest expense over the term of the 2022 Notes using the effective interest method.
−Removed: During fiscal 2020, the Company paid $ 305.1 million in cash to repurchase $ 259.4 million aggregate principal amount of the 2022 Notes.
−Removed: The Company recognized a loss on debt extinguishment of $ 4.1 .
−Removed: million during fiscal 2020, which was recorded in interest expense in the Consolidated Statements of Income.
−Removed: On January 6, 2021, the Company issued a notice of redemption for the remaining $ 140.6 million principal amount of the 2022 Notes.
−Removed: The redemption will occur on March 22, 2021, unless earlier converted.
−Removed: The principal balances of the notes were separated into liability and equity components, and recorded initially at fair value.
+Added: Convertible Debt, Net
+Added: The principal balances of the 2025 Notes and 2022 Notes (together, the "Notes") were separated into liability and equity components, and recorded initially at fair value.
The excess of the principal amounts of the liability components over their carrying amounts represent the debt discount, which are amortized to interest expense over the term of the Notes using the effective interest method.
8 unchanged sentences
The liability components of the Notes are recorded in convertible debt on the Consolidated Balance Sheet.
−Removed: The equity components of the notes are recorded in additional paid-in capital.
+Added: The equity components of the Notes are recorded in stockholders’ equity.
The effective interest rate for the liability component was 5.336 % for the 2025 Notes and 4.75 % for the 2022 Notes.
−Removed: As of January 2, 2021, the remaining period over which the debt discount and debt issuance costs will be amortized was 4.5 years for the 2025 Notes and 0.2 years for the 2022 Notes.
+Added: As of January 1, 2022, the remaining period over which the debt discount and debt issuance costs will be amortized was 3.5 years for the 2025 Notes.
+Added: With the Company’s adoption of ASU 2020-06 in fiscal 2022, the principal balance of the 2025 Notes will no longer be separated between liability and equity components.
+Added: This will result in an increase to the carrying value of its convertible debt by $ 78.5 million, representing the unamortized debt discount, with an offsetting reduction in stockholders’ equity.
Interest expense related to the notes was comprised of the following (in thousands):
5 unchanged sentences
The credit facility includes a $ 25 million letter of credit sublimit and a $ 10 million swingline loan sublimit.
−Removed: The Company also has an option to increase the size of the borrowing capacity by up to the greater of an aggregate of $ 250 million and 100 % of EBITDA, plus an amount that would not cause a secured leverage ratio (funded debt secured by assets/EBITDA) to exceed 3.25 to 1.00, subject to certain conditions.
−Removed: On March 27, 2020, the Company borrowed $ 310 million under the credit facility.
−Removed: On June 1, 2020, the Company repaid in full the outstanding balance of the credit facility.
+Added: The Company also has an option to increase the size of the borrowing capacity by up to the greater of an aggregate of $ 250 million and 100 % of EBITDA of the last four fiscal quarters, plus an amount that would not cause a secured leverage ratio (funded debt secured by assets/EBITDA) to exceed 3.25 to 1.00, subject to certain conditions.
Silicon Laboratories Inc.
8 unchanged sentences
The Company’s obligations under the credit facility are guaranteed by the Guarantors and are secured by a security interest in substantially all assets of the Company and the Guarantors.
+Added: As of January 1, 2022, no amounts were outstanding on the credit facility.
The Company leases certain facilities under operating lease agreements that expire at various dates through 2030.
Some of these arrangements contain renewal options and require the Company to pay taxes, insurance and maintenance costs.
−Removed: The Company adopted ASC Topic 842, Leases , on December 30, 2018, the first day of its fiscal 2019.
−Removed: Lease costs for operating leases were $ 5.6 million and $ 5.8 million during fiscal 2020 and 2019, respectively.
−Removed: The Company elected the practical expedient to not provide comparable presentation for periods prior to adoption.
−Removed: Rent expense for operating leases was $ 6.0 million for fiscal 2018.
+Added: Lease costs for operating leases were $ 7.4 million, $ 5.6 million and $ 5.8 million during fiscal 2021, 2020 and 2019, respectively.
Supplemental Lease Information
16 unchanged sentences
Total lease liabilities
+Added: The Company leases a portion of its headquarter facilities to other tenants.
+Added: Lease income from operating leases was $ 4.9 million, $ 3.2 million and $ 4.0 million during fiscal 2021, 2020 and 2019, respectively.
Commitments and Contingencies
−Removed: Investment Commitment
−Removed: The Company has committed to invest up to $ 10.0 million in a limited partnership, of which approximately $ 7.8 million was funded through January 2, 2021.
Legal Proceedings
1 unchanged sentence
While the ultimate results cannot be predicted with certainty, the Company does not expect them to have a material adverse effect on its Consolidated Financial Statements.
−Removed: Stockholders’ Equity
−Removed: The Company issued 0.6 million shares of common stock during fiscal 2020.
−Removed: Share Repurchase Programs
−Removed: In April 2020, the Board of Directors terminated the Company’s existing share repurchase program, effective immediately, which had an authorization amount of $ 200 million and a termination date of December 2020.
−Removed: The Company repurchased 0.2 million shares, 0.3 million shares and 0.4 million shares of its common stock for $ 16.3 million, $ 26.7 million and $ 39.3 million during fiscal 2020, 2019 and 2018, respectively.
−Removed: These shares were retired upon repurchase.
−Removed: The Company groups its revenues into two categories, based on the markets and applications in which its products may be used.
−Removed: The following disaggregates the Company's revenue by product category (in thousands):
−Removed: Internet of Things
−Removed: Infrastructure and automotive
+Added: Share Repurchases
+Added: The Company repurchased 6.5 million shares, 0.2 million shares and 0.3 million shares of its common stock for $ 1.15 billion, $ 16.3 million and $ 26.7 million during fiscal 2021, 2020 and 2019, respectively.
+Added: Shares repurchased in fiscal 2021 included purchases of 4.0 million shares through a “modified Dutch Auction” tender offer, 1.7 million shares through an accelerated share repurchase (“ASR”) agreement and 0.8 million shares through the Company’s existing share repurchase program.
+Added: The tender offer commenced on August 3, 2021 and expired on August 30, 2021.
+Added: Shares repurchased through the tender offer were priced at $ 160.00 per share, for an aggregate cost of $ 640.7 million, excluding fees and expenses relating to the tender offer.
+Added: Under the ASR Agreement, the Company will repurchase an aggregate of $ 400 million of its common stock.
+Added: In fiscal 2021, the Company received an aggregate initial share delivery of approximately 1.7 million shares, with the remaining shares, if any, expected to be delivered in the first fiscal quarter of 2022.
+Added: Shares purchased through the tender offer, ASR agreement and share repurchase program were effectively retired upon repurchase.
+Added: Revenues were generated predominately by sales of the Company’s mixed-signal products.
+Added: Revenue is recognized when control of the promised goods or services is transferred to the customer, which typically occurs upon delivery.
+Added: The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer and may include fixed or variable amounts.
+Added: Variable consideration that does not meet revenue recognition criteria is deferred.
Silicon Laboratories Inc.
2 unchanged sentences
Revenues (Continued)
−Removed: The Company has combined its previous product groups, Infrastructure, Broadcast and Access, into the Infrastructure and automotive product group.
−Removed: Prior periods were retrospectively adjusted.
A portion of the Company’s sales are made to distributors under agreements allowing certain rights of return and/or price protection related to the final selling price to the end customers.
3 unchanged sentences
Direct customers
−Removed: The Company periodically reviews the assumptions used to estimate consideration it will be entitled to receive from customers.
−Removed: In fiscal 2020, the Company adjusted certain assumptions used to estimate the constraint on variable consideration based on an analysis of prior period estimates versus actual experience.
−Removed: These updated assumptions and resulting revision in estimates of variable consideration increased revenue by $ 11.9 million in the fourth quarter of fiscal 2020.
Stock-Based Compensation
+Added: Information in this footnote is inclusive of both continuing and discontinued operations, except as noted.
In fiscal 2009, the stockholders of the Company approved the 2009 Stock Incentive Plan (the “2009 Plan”) and the 2009 Employee Stock Purchase Plan (the “2009 Purchase Plan”).
−Removed: In fiscal 2017, the stockholders of the Company approved amendments to both the 2009 Plan and the 2009 Purchase Plan.
+Added: In fiscal 2017 and fiscal 2021, the stockholders of the Company approved amendments to both the 2009 Plan and the 2009 Purchase Plan.
The purpose of the amendments was to authorize additional shares of common stock for issuance, to comply with changes in applicable law, to improve the Company’s corporate governance and to implement other best practices.
7 unchanged sentences
To the extent awards granted under the 2009 Plan terminate, expire or lapse for any reason, or are settled in cash, shares subject to such awards will again be available for grant.
+Added: Stock Grants and Modifications
The Company granted to its employees 0.6 million, 0.7 million and 0.7 million shares of full value awards and no stock options from the 2009 Plan during fiscal 2021, 2020 and 2019, respectively.
+Added: The Company recorded $ 7.8 million in selling, general and administrative expense during fiscal 2021 in connection with the modification of certain equity awards.
+Added: The modifications were pursuant to employee terminations.
+Added: There were no other significant modifications made to any stock grants during fiscal 2021, 2020 or 2019.
+Added: Included in the full value awards granted under the 2009 Plan in fiscal 2021 were 116,809 performance-based stock awards (PSUs).
+Added: PSUs provide for the rights to acquire a number of shares of common stock for no cash consideration based upon the achievement of specified revenue objectives during the year.
+Added: The requisite service period for these PSUs is approximately three years from the date of grant.
+Added: There were no performance stock units (PSUs) granted during fiscal 2020 or 2019.
Silicon Laboratories Inc.
5 unchanged sentences
The requisite service period for these MSUs is also the vesting period, which is generally three years .
−Removed: The performance criteria of the MSUs granted in 2018 measures the difference between the total stockholders’ return of the Company against that of the PHLX Semiconductor Sector Total Return Index.
MSUs granted in 2020 and 2019 measure the relative performance of the total stockholders’ return of the Company against that of a selected benchmarked group of companies.
−Removed: Also included in the full value awards granted under the 2009 Plan during fiscal 2018 were 41,000 performance-based stock awards (PSUs).
−Removed: There were no PSUs granted during fiscal 2020 or 2019.
−Removed: PSUs provide for the rights to acquire a number of shares of common stock for no cash consideration based upon the achievement of specified revenue objectives during the year.
−Removed: The requisite service period for these PSUs is approximately three years from the date of grant.
+Added: There were no MSUs granted in fiscal 2021.
2009 Employee Stock Purchase Plan
21 unchanged sentences
Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of stock-based compensation expense to be recognized in future periods.
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Stock-Based Compensation (Continued)
The fair values of stock options and RSUs are amortized as compensation expense on a straight-line basis over the vesting period of the grants.
3 unchanged sentences
Compensation expense recognized is shown in the operating activities section of the Consolidated Statements of Cash Flows.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Stock-Based Compensation (Continued)
The fair values estimated from the Black-Scholes option-pricing model for ESPP shares granted were calculated using the following assumptions:
13 unchanged sentences
Stock Options
−Removed: Outstanding at December 28, 2019
Outstanding at January 2, 2021
+Added: Outstanding at January 1, 2022
Vested at January 1, 2022 and expected to vest
2 unchanged sentences
RSAs and RSUs
−Removed: Outstanding at December 28, 2019
+Added: Outstanding at January 2, 2021
Vested or issued
2 unchanged sentences
Outstanding at January 1, 2022 and expected to vest
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Stock-Based Compensation (Continued)
Weighted-Average
PSUs and MSUs
−Removed: Outstanding at December 28, 2019
+Added: Outstanding at January 2, 2021
Earned or issued
2 unchanged sentences
Outstanding at January 1, 2022 and expected to vest
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Stock-Based Compensation (Continued)
The following summarizes the Company’s weighted average fair value at the date of grant:
15 unchanged sentences
Income tax benefit
−Removed: The decrease in income tax benefit in fiscal 2019 was primarily due to a change in the Company’s position related to the treatment of stock-based compensation within its intercompany cost-sharing arrangement.
−Removed: The Company had approximately $ 78.6 million of total unrecognized compensation costs related to equity grants from the 2009 Plan as of January 2, 2021 that are expected to be recognized over a weighted-average period of approximately 2.2 years.
+Added: Share-based compensation – continuing operations
+Added: Share-based compensation – discontinued operations, net
+Added: The Company had approximately $ 74.2 million of total unrecognized compensation cost related to equity grants under the 2009 Plan as of January 1, 2022 that is expected to be recognized over a weighted-average period of approximately 2.4 years.
There were no significant stock-based compensation costs capitalized into assets in any of the periods presented.
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Stock-Based Compensation (Continued)
As of January 1, 2022, the Company had reserved shares of common stock for future issuance as follows (in thousands):
2 unchanged sentences
Total shares reserved
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
Employee Benefit Plan
3 unchanged sentences
The Company contributed $ 3.5 million, $ 4.2 million and $ 3.9 million to the 401(k) Plan during fiscal 2021, 2020 and 2019, respectively.
−Removed: Income before income taxes includes the following components (in thousands):
+Added: Loss from continuing operations before income taxes includes the following components (in thousands):
The provision (benefit) for income taxes consists of the following (in thousands):
2 unchanged sentences
Provision (benefit) for income taxes
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Income Taxes (Continued)
The reconciliation of the federal statutory tax rate to the Company’s effective tax rate is as follows:
4 unchanged sentences
(Nondeductible) nontaxable foreign items
−Removed: State tax expense
−Removed: Release of prior year unrecognized tax benefits
Nondeductible officer compensation
1 unchanged sentence
Excess tax benefit of stock-based compensation
+Added: Other tax effects of equity compensation
Change in prior period valuation allowance
−Removed: One-time impacts of tax reform
(Nondeductible) nontaxable domestic items
+Added: Net operating loss not benefited
Effective tax rate
−Removed: The effective tax rate for fiscal 2020 decreased from fiscal 2019 primarily due to a fiscal 2019 change in the Company’s position related to the treatment of stock-based compensation within its intercompany cost-sharing arrangement offset by the increased impact of fiscal 2020 permanent tax differences.
−Removed: The effective tax rate for fiscal 2019 increased from fiscal 2018 primarily due to a change in the Company’s financial statement position related to the treatment of stock-based compensation within its intercompany cost-sharing arrangement.
−Removed: The Company’s operations in Singapore are subject to reduced tax rates through June 30, 2024, as long as certain conditions are met.
−Removed: The impact of the tax holiday decreased foreign taxes by $ 1.8 million in fiscal 2020 (representing $ 0.04 per diluted share), by $ 4.0 million in fiscal 2019 (representing $ 0.09 per diluted share), and by $ 8.1 million in fiscal 2018 (representing $ 0.18 per diluted share).
−Removed: The Tax Cuts and Jobs Act was enacted in the U.S.
−Removed: on December 22, 2017 and required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred from U.S income tax under U.S.
−Removed: The Company elected to pay the transition tax over the eight-year period provided in the Act.
−Removed: As of January 2, 2021, the unpaid balance of its transition tax obligation is $ 21.4 million, which is payable between April 2022 and April 2025.
−Removed: This is recorded as a component of other non-current liabilities in the Consolidated Balance Sheet.
Silicon Laboratories Inc.
2 unchanged sentences
Income Taxes (Continued)
+Added: The effective tax rate for fiscal 2021 decreased from fiscal 2020 primarily due to the adoption of FASB ASU 2019-12, Simplifying the Accounting for Income Taxes, in 2021 and an increase in the beginning of year valuation allowance on deferred tax assets for state attribute carryforwards.
+Added: The effective tax rate for fiscal 2020 increased from fiscal 2019 primarily due to a fiscal 2019 change in the Company’s position related to the treatment of stock-based compensation within its intercompany cost-sharing arrangement offset by the increased impact of fiscal 2020 permanent tax differences.
+Added: The higher provision for income taxes for fiscal 2021 was primarily due to the adoption of ASU 2019-12 as of the beginning of fiscal 2021.
+Added: Under ASU 2019-12, which is being applied prospectively from the date of adoption, the income tax benefit of a loss from continuing operations should be reallocated to discontinued operations if the Company would be unable to benefit from the loss without considering the income from discontinued operations.
+Added: As such, the income tax benefit from net operating losses associated with continuing operations for fiscal 2021 was reallocated to discontinued operations.
+Added: Prior to ASU 2019-12, if the Company reported a loss from continuing operations and income from discontinued operations, income from discontinued operations would be considered in determining the income tax benefit allocated to continuing operations.
+Added: Additionally, for fiscal 2021 there was an increase in the beginning of year valuation allowance on deferred tax assets for state attribute carryforwards as a result of changes in state tax estimates, primarily due to the divestiture of the infrastructure and automotive business.
+Added: Tax on the gain from the divestiture of the infrastructure and automotive business of $ 346.9 million was recorded in discontinued operations for the current period, as well as additional tax benefits associated with discontinued operations of $ 7.2 million for fiscal 2021.
+Added: As of January 1, 2022, income taxes payable of $ 74.9 million recorded in connection with the gain from the divestiture was included in other current liabilities in the Consolidated Balance Sheet.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Income Taxes (Continued)
+Added: The Tax Cuts and Jobs Act was enacted in the U.S.
+Added: on December 22, 2017 and required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred from U.S income tax under U.S.
+Added: The Company elected to pay the transition tax over the eight-year period provided in the Act.
+Added: As of January 1, 2022, the unpaid balance of its transition tax obligation was $ 21.4 million, which is payable between April 2022 and April 2025.
+Added: This was recorded as components of other current liabilities and other non-current liabilities in the Consolidated Balance Sheet in the amounts of $ 2.4 million and $ 19.0 million, respectively.
+Added: The Company has made an accounting policy election to treat global intangible low-taxed income (GILTI) as a period expense when incurred.
Deferred Income Taxes
Deferred tax assets and liabilities are recorded for the estimated tax impact of temporary differences between the tax basis and book basis of assets and liabilities.
−Removed: Significant components of the Company’s deferred taxes as of January 2, 2021 and December 28, 2019 are as follows (in thousands):
+Added: Significant components of the Company’s deferred taxes as of January 1, 2022 and January 2, 2021 were as follows (in thousands):
Deferred tax assets:
1 unchanged sentence
Tax credit carryforwards
−Removed: Stock-based compensation
Intangible assets
−Removed: Capitalized research and development
Deferred income on shipments to distributors
−Removed: Accrued liabilities and other
+Added: Accrued liabilities
Valuation allowance
1 unchanged sentence
Intangible assets
+Added: Unrealized gain on equity method investment
Prepaid expenses and other
Net deferred tax assets (liabilities)
−Removed: As of January 2, 2021, the Company had federal net operating loss and research and development tax credit carryforwards of approximately $ 23.2 million and $ 1.9 million, respectively, as a result of the Silicon Clocks, Spectra Linear and Ember acquisitions.
+Added: As of January 1, 2022, the Company had federal net operating loss and research and development tax credit carryforwards of approximately $ 18.4 million and $ 1.8 million, respectively.
These carryforwards expire in fiscal years 2022 through 2031.
Recognition of these loss and credit carryforwards is subject to an annual limit, which may cause them to expire before they are used.
−Removed: Additionally, as of January 2, 2021, the Company had generated $ 10.5 million of federal research and development credit carryforwards and $ 0.6 million of foreign tax credit carryforwards.
−Removed: The federal research and development credits expire in fiscal years 2039 through 2040, and the foreign tax credits expire in 2030.
−Removed: These credits are not currently subject to an annual limitation.
The Company also had state loss, state tentative minimum tax credit, and state research and development tax credit carryforwards of approximately $ 30.6 million, $ 0.5 million, and $ 11.9 million, respectively.
−Removed: A portion of these loss and credit carryforwards was generated by the Company and a portion was acquired through the Integration Associates, Silicon Clocks, Spectra Linear and Zentri acquisitions.
Certain of these carryforwards expire in fiscal years 2025 through 2036, and others do not expire.
5 unchanged sentences
A valuation allowance is established against a deferred tax asset when it is more likely than not that the deferred tax asset will not be realized.
−Removed: The Company maintains a valuation allowance with respect to certain deferred tax assets relating to state research and development tax credit and state net operating loss carryforwards.
+Added: The Company maintains a valuation allowance with respect to certain deferred tax assets relating to state research and development tax credits, state net operating loss carryforwards and state alternative minimum tax credits.
The following table summarizes the activity related to the valuation allowance for deferred tax assets (in thousands):
1 unchanged sentence
Year ended January 1, 2022
−Removed: Year ended December 28, 2019
+Added: Year ended January 2, 2021
Year ended December 28, 2019
6 unchanged sentences
Additions based on tax positions related to current year
−Removed: Additions based on tax positions related to prior years
Reductions based on tax positions related to prior years
−Removed: Reductions for tax positions as a result of a lapse of the applicable statute of limitations
Ending balance
−Removed: As of January 2, 2021, December 28, 2019 and December 29, 2018, the Company had gross unrecognized tax benefits, inclusive of interest, of $ 3.0 million, $ 2.4 million and $ 2.1 million, respectively, of which $ 2.1 million, $ 1.9 million and $ 2.1 million, respectively, would affect the effective tax rate if recognized.
+Added: As of January 1, 2022, January 2, 2021 and December 28, 2019, the Company had gross unrecognized tax benefits, inclusive of interest, of $ 3.9 million, $ 3.0 million and $ 2.4 million, respectively, of which $ 3.9 million, $ 2.1 million and $ 1.9 million, respectively, would affect the effective tax rate if recognized.
The Company recognizes interest and penalties related to unrecognized tax benefits in the provision (benefit) for income taxes.
5 unchanged sentences
The Company plans to exhaust all available administrative remedies, and if unable to resolve this matter through administrative remedies with the NTA, the Company plans to pursue judicial remedies.
−Removed: Silicon Laboratories Inc.
−Removed: Notes to Consolidated Financial Statements (Continued)
−Removed: January 2, 2021
−Removed: Income Taxes (Continued)
The Company believes that it has accrued adequate reserves related to all matters contained in tax periods open to examination.
2 unchanged sentences
The Company is not currently under audit in any major taxing jurisdiction.
−Removed: The Company does not expect material changes to its gross unrecognized tax benefits in the next 12 months.
+Added: Silicon Laboratories Inc.
+Added: Notes to Consolidated Financial Statements (Continued)
+Added: January 1, 2022
+Added: Income Taxes (Continued)
+Added: The Company believes it is reasonably possible that its gross unrecognized tax benefits will decrease by approximately $ 0.5 million, inclusive of interest, in the next 12 months due to the lapse of the statute of limitations.
Segment Information
2 unchanged sentences
The chief operating decision maker allocates resources and assesses performance of the business and other activities at the operating segment level.
−Removed: The Company groups its products into two categories, based on the markets and applications in which the products may be used.
−Removed: See Note 14, Revenues , for a summary of the Company’s revenue by product category.
Revenue is attributed to a geographic area based on the shipped-to location.
7 unchanged sentences
Quarterly financial information for fiscal 2021 and 2020 is as follows.
+Added: The financial data for fiscal 2020 and the first quarter of fiscal 2021 has been recast to reflect the sale of the Company’s infrastructure and automotive business as discontinued operations.
+Added: The sale of this business closed on July 26, 2021.
+Added: See Note 3, Discontinued Operations , to the Consolidated Financial Statements for additional information.
The first quarter of fiscal 2020 had 14 weeks.
All other quarterly periods reported here had 13 weeks (in thousands, except per share amounts):
−Removed: Operating income
+Added: Income (loss) from continuing operations
Net income (loss)
−Removed: Earnings (loss) per share:
−Removed: Operating income
+Added: Basic earnings (loss) per share:
+Added: Continuing operations
+Added: Diluted earnings (loss) per share:
+Added: Continuing operations
+Added: Loss from continuing operations
Net income (loss)
−Removed: Earnings (loss) per share:
+Added: Basic earnings (loss) per share:
+Added: Continuing operations
+Added: Diluted earnings (loss) per share:
+Added: Continuing operations
+Added: (1) Includes a gain on sale of our infrastructure and automotive business of $2.1 billion, net of tax.
(2) Includes an adjustment of $6.9 million to increase revenue resulting from a change in the assumptions used to estimate variable consideration.
−Removed: (2) Includes a discrete charge to the income tax provision of $28.1 million ($0.64 per share) related to a net deferred tax asset previously recognized in connection with intercompany cost sharing arrangements.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.